Sign In
Buy ADCT
$1.15
+0.0600 (+5.50%)
At Close: Jun 23, 2026
ADC Therapeutics stock soars 56% in trading debut
04:05pm, Friday, 15'th May 2020
ADC Therapeutics S.A. shares rocketed 56% Friday in their trading debut, after the Swiss biotech's initial public offering priced above its proposed price range and underwriters increased the size of
ADC Therapeutics prices IPO at $19 a share, above the price range
10:13am, Friday, 15'th May 2020
ADC Therapeutics S.A. priced its initial public offering at $19 a share late Thursday, above its proposed price range of $16 to $18, and increased the size to 12.2 million shares from 10.3 million wh
ADC Therapeutics Announces Pricing of Upsized Initial Public Offering
01:47am, Friday, 15'th May 2020
LAUSANNE, Switzerland, May 14, 2020 -- ADC Therapeutics SA, a late clinical-stage oncology-focused biotechnology company pioneering the development and commercialization of.
ADC Therapeutics sets IPO terms, to be valued at up to $1 billion
10:56am, Thursday, 14'th May 2020
ADC Therapeutics S.A. set terms of its initial public offering, as the Switzerland-based biotechnology company focused on cancer treatments looks to raise up to $185.3 million. ADC is offering 10,295
